Medicare Enrolled

Dr. Alexander Wong, MD

Medical Oncology · Sugar Land, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
16659 SOUTHWEST FWY, Sugar Land, TX 77479
2814910561
Registered in NPPES since 2005
NPI: 1992792402 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wong? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wong

Dr. Alexander Wong is a medical oncology specialist in Sugar Land, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wong performed 1,051 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Wong received a total of $10,427 from 68 pharmaceutical and/or device companies across 506 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wong is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 1,051 Medicare services $10,427 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,051
Medicare services
Bottom 48% in TX for medical oncology
Not available
Unique patients (not deduplicated)
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
521 $85 $332
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
226 $62 $272
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
130 $22 $105
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
97 $98 $450
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
77 $110 $417
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
21.6% high complexity
0.0% medium
78.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,427
Total received (2018-2024)
Avg $1,490/year across 7 years
Top 38% in TX for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
506
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,580
2023
$1,688
2022
$1,155
2021
$1,343
2020
$1,040
2019
$1,944
2018
$1,679

Payments by company (2024)

Janssen Biotech, Inc.
$180
Merck Sharp & Dohme LLC
$169
Astellas Pharma US Inc
$165
Celgene Corporation
$164
Novartis Pharmaceuticals Corporation
$159
Bayer Healthcare Pharmaceuticals Inc.
$102
Spectrum Pharmaceuticals Inc.
$95
E.R. Squibb & Sons, L.L.C.
$73
Daiichi Sankyo Inc.
$60
PFIZER INC.
$47
GlaxoSmithKline, LLC.
$46
Alexion Pharmaceuticals, Inc.
$38
PUMA BIOTECHNOLOGY, INC.
$37
ABBVIE INC.
$35
EMD Serono, Inc.
$33
Janssen Pharmaceuticals, Inc
$27
PharmaEssentia USA Corporation
$24
Lilly USA, LLC
$22
Gilead Sciences, Inc.
$21
Rigel Pharmaceuticals, Inc.
$20
Eisai Inc.
$19
Amneal Pharmaceuticals LLC
$16
Inari Medical, Inc.
$14
Pharmacosmos Therapeutics Inc.
$14
Top 3 companies account for 32.5% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$720
Merck Sharp & Dohme Corporation
$687
Astellas Pharma US Inc
$680
E.R. Squibb & Sons, L.L.C.
$671
AstraZeneca Pharmaceuticals LP
$656
PFIZER INC.
$505
Lilly USA, LLC
$461
Celgene Corporation
$439
Novartis Pharmaceuticals Corporation
$427
Janssen Biotech, Inc.
$414
Merck Sharp & Dohme LLC
$375
McKesson Specialty Care Distribution, LLC
$266
GENZYME CORPORATION
$212
Bayer Healthcare Pharmaceuticals Inc.
$203
Alexion Pharmaceuticals, Inc.
$203
Bayer HealthCare Pharmaceuticals Inc.
$171
GlaxoSmithKline, LLC.
$169
Rigel Pharmaceuticals, Inc.
$165
Taiho Oncology, Inc.
$154
Seagen Inc.
$149
Boehringer Ingelheim Pharmaceuticals, Inc.
$147
Genentech USA, Inc.
$145
Gilead Sciences, Inc.
$143
Spectrum Pharmaceuticals Inc.
$134
Daiichi Sankyo Inc.
$133
NOVARTIS PHARMACEUTICALS CORPORATION
$128
Incyte Corporation
$125
Kyowa Kirin, Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$124
Janssen Pharmaceuticals, Inc
$115
PharmaEssentia USA Corporation
$114
EMD Serono, Inc.
$114
Seattle Genetics, Inc.
$76
Mylan Institutional Inc.
$76
Organon LLC
$69
Teva Pharmaceuticals USA, Inc.
$61
Pharmacyclics LLC, An AbbVie Company
$56
ABBVIE INC.
$56
Amneal Pharmaceuticals LLC
$53
TerSera Therapeutics LLC
$50
TAIHO ONCOLOGY, INC.
$43
Ipsen Biopharmaceuticals, Inc
$42
Puma Biotechnology, Inc.
$38
PUMA BIOTECHNOLOGY, INC.
$37
Regeneron Healthcare Solutions, Inc.
$37
Dova Pharmaceuticals
$32
Array BioPharma Inc.
$30
AbbVie Inc.
$27
ARRAY BIOPHARMA INC
$26
Lexicon Pharmaceuticals, Inc.
$23
TESARO, Inc.
$23
Sumitomo Pharma America, Inc.
$22
BeiGene USA, Inc.
$21
Shield Therapeutics Inc
$21
Clovis Oncology, Inc.
$20
Ferring Pharmaceuticals Inc.
$20
Epizyme, Inc.,
$20
Heron Therapeutics, Inc.
$20
Eisai Inc.
$19
Stemline Therapeutics Inc.
$18
APO-PHARMA USA, INC.
$17
Jazz Pharmaceuticals Inc.
$17
Mylan Pharmaceuticals Inc.
$16
Coherus Biosciences Inc.
$16
Inari Medical, Inc.
$14
Pharmacosmos Therapeutics Inc.
$14
Acrotech Biopharma LLC
$12
Abbott Laboratories
$11
Top 3 companies account for 20.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · ALIMTA · AVASTIN · Alecensa · Aliqopa · BALVERSA · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Braftovi · CABLIVI · CALQUENCE · CINVANTI · COSELA · CYRAMZA · DEFERIPRONE · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Enhertu · Erleada · FARESTON · FIRMAGON · FLOWTRIEVER CATHETER · Fabhalta · Folotyn · Fulphila · GILOTRIF · IBRANCE · ICLUSIG · IMFINZI · INLYTA · INQOVI · Imbruvica · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONOFERRIC · MVASI · MitraClip System · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · Orserdu · POTELIGEO · PROMACTA · Padcev · Perjeta · Pomalyst · REBLOZYL · ROLVEDON · Revlimid · Rezlidhia · Rubraca · S · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · Stellant · Stivarga · TABRECTA · TAGRISSO · TALZENNA · TASIGNA · TAZVERIK · TUKYSA · Tarceva · Tavalisse · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VYXEOS · Vectibix · XALKORI · XARELTO · XGEVA · XTANDI · Xermelo · Xospata · Xtandi · ZEJULA · ZOLADEX · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a medical oncology specialist in Sugar Land?
Compare medical oncologists in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists in nearby ZIP areas
177
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wong is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wong experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Wong performed 521 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Wong receive payments from pharmaceutical companies?
Yes. Dr. Wong received a total of $10,427 from 68 companies across 506 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wong's costs compare to other medical oncologists in Sugar Land?
Dr. Wong's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →